Current Clinical Trials
UNDER EVALUATION: Depemokimab as an Extended treatmeNt DURation biologic in Adults with • COPD and type 2 inflammation ENDURA-1/ENDURA-2
- Rancho Mirage, CA
- Accepting new patients
Description
Summary
A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. Protocol title: ENDURA-1/ENDURA-2: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation.Official Title
UNDER EVALUATION: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. Protocol title: ENDURA-1/ENDURA-2: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation.Keywords
COPDLead Scientist at Eisenhower Health
Clinical Study Details
- Accepting new patients
- Interventional
- June 17, 2026
